1. Home
  2. KBSX vs IMMP Comparison

KBSX vs IMMP Comparison

Compare KBSX & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

HOLD

Current Price

$1.52

Market Cap

65.8M

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$2.63

Market Cap

264.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBSX
IMMP
Founded
1976
1987
Country
Taiwan
Australia
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8M
264.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KBSX
IMMP
Price
$1.52
$2.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.5K
1.7M
Earning Date
11-19-2025
02-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$44,890,395.00
$3,306,742.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
30.46
31.28
52 Week Low
$1.26
$1.32
52 Week High
$15.48
$3.53

Technical Indicators

Market Signals
Indicator
KBSX
IMMP
Relative Strength Index (RSI) 50.86 76.11
Support Level $1.31 $1.67
Resistance Level $1.60 $3.53
Average True Range (ATR) 0.04 0.24
MACD 0.01 0.09
Stochastic Oscillator 62.07 51.62

Price Performance

Historical Comparison
KBSX
IMMP

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: